| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 604 | 8.974 | 3.852 | 6.924 | 8.366 | 38.755 | 147.016 |
| Total Income - EUR | - | - | - | 610 | 8.974 | 5.920 | 8.877 | 8.366 | 38.755 | 159.445 |
| Total Expenses - EUR | - | - | - | 3.998 | 8.636 | 3.072 | 3.459 | 5.638 | 32.434 | 100.313 |
| Gross Profit/Loss - EUR | - | - | - | -3.388 | 338 | 2.848 | 5.418 | 2.728 | 6.321 | 59.132 |
| Net Profit/Loss - EUR | - | - | - | -3.406 | 69 | 2.776 | 5.308 | 2.482 | 5.550 | 54.926 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
Check the financial reports for the company - Grad Uroderm Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 10.237 | 8.764 | 8.205 | 6.404 | 4.717 | 35.281 | 49.658 |
| Current Assets | - | - | - | 300 | 538 | 1.562 | 112 | 3.233 | 5.230 | 32.698 |
| Inventories | - | - | - | 0 | 0 | 378 | 0 | 0 | 0 | 1.260 |
| Receivables | - | - | - | 0 | 0 | 84 | 57 | 560 | 465 | 576 |
| Cash | - | - | - | 300 | 538 | 1.101 | 56 | 2.673 | 4.765 | 30.862 |
| Shareholders Funds | - | - | - | -3.363 | -3.229 | -392 | 4.925 | 7.422 | 12.949 | 67.803 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 13.900 | 15.482 | 8.158 | 1.592 | 529 | 27.562 | 14.554 |
| Income in Advance | - | - | - | 0 | 0 | 2.001 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Grad Uroderm Medical S.r.l.